AEGERION PHARMACEUTICALS Stock Price
$60.09 
Change:
-0.50 -0.41% Volume:
53,231
Live Stock Prices
You need Flash Player to see the chart, please download from the link below
Todays Chart
You need Flash Player to see the chart, please download from the link below
Month Chart
Todays High: 61.09 | Todays Low: 59.22 | Open: 60.59 | Last Close: 61.1
52 Wk High: 63.7 | 52 Wk Low: 12.865 | Todays Pivot: 60.13 | Pre market open: 35.51
Sector: 
Online News For Aegerion Pharmaceuticals
|
Aegerion Pharmaceuticals Announces Webcast of Investor Presentations at ... - NASDAQ
Fri, 24 May 2013 12:04CAMBRIDGE, Mass., May 24, 2013 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc.(Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat debilitating and often ...
|
|
How Marc Beer Scipted Aegerion Pharma's Success Story - Forbes India
Thu, 23 May 2013 03:10The result of that listening is one of this year's biggest biotech success stories: Aegerion Pharmaceuticals. On Christmas Eve, less than two years after Beer took the helm, the tiny company won approval from the Food & Drug Administration to sell its ...
|
|
Is Aegerion Pharmaceuticals, Inc. (AEGR) Now a Sell? - Insider Monkey (blog)
Mon, 20 May 2013 13:42Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) had previously reported that patient cost would be between $200,000 and $300,000 annually for Juxtapid. According to slides from the company's presentation on Wednesday, maintenance with the drug will ...
|
|
Aegerion Pharmaceuticals, Inc. (AEGR), TESARO Inc (TSRO), And Three ... - Insider Monkey (blog)
Mon, 20 May 2013 14:51$1 billion has a nice ring to it When Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) speaks, people listen -- and buy the company's stock. Shares jumped nearly 34% this week, largely on a presentation made by Aegerion at the Bank of America Merrill ...
|
|
Aegerion Pharmaceuticals Price Target Raised to $50.00 at Jefferies Group ... - Mideast Time
Wed, 22 May 2013 14:15Aegerion Pharmaceuticals logo Aegerion Pharmaceuticals (NASDAQ: AEGR) had its price target increased by Jefferies Group from $46.00 to $50.00 in a research report released on Monday morning, Analyst Ratings Network reports. Jefferies Group currently ...
|
|
Aegerion Pharmaceuticals (AEGR +32%) goes on a tear today, after CEO Marc ... - Seeking Alpha
Thu, 16 May 2013 19:17Aegerion Pharmaceuticals (AEGR +32%) goes on a tear today, after CEO Marc Beer painted an upbeat picture for its rare-cholesterol-disease drug Juxtapid at a conference late yesterday. According to slides, Juxtapid will cost about $235K at initiation ...
|
AEGR Chart
You need Flash Player to see the chart, please download from the link below
Want To Add This Quote To Your Site?
With our stock widgets you can add a real time Aegerion Pharmaceuticals quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for AEGR to choose from. Visit here to build your stock quote widget »
